ArticleMethodsX2026
HieraMed: A hierarchical representation framework for next-visit diagnosis prediction from longitudinal electronic health records.
Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Next-visit diagnosis prediction from electronic health records (EHRs) is a challenging multi-label prediction task because predictive information is distributed across medical-code semantics, heterogeneous visit contents, and longitudinal patient history. This article presents HieraMed, a hierarchical method for multi-label next-visit diagnosis prediction from structured EHR data. HieraMed first converts standardized medical codes into semantically enriched embeddings using natural-language descriptions. It then integrates diagnoses, procedures, and medications within each encounter into visit-level representations, and models visit sequences with a Liquid Neural Network to capture patient-state evolution over time. The method was evaluated on MIMIC-III and MIMIC-IV. HieraMed achieved a visit-level precision@20 of 67.80% and a code-level accuracy@20 of 63.39% on MIMIC-III, and 71.65% and 65.64% on MIMIC-IV. Compared with the best baseline, it improved visit-level precision@20 by 3.02 percentage points on MIMIC-III and 2.66 percentage points on MIMIC-IV. These results indicate that organizing EHR data through a code-visit-patient hierarchy yields consistent improvements in next-visit diagnosis prediction under the evaluated benchmark settings.•HieraMed provides a hierarchical modelling pipeline for next-visit diagnosis prediction from structured EHR data.•The method integrates code-level semantic augmentation, visit-level heterogeneous event aggregation, and patient-level temporal modelling.•Validation on MIMIC-III and MIMIC-IV shows consistent improvements over strong baseline models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.